Experimental endocarditis model of methicillin resistant Staphylococcus aureus (MRSA) in rat
Related Experiment Video
Updated: May 21, 2026
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Wessam Abdel Hady1, Arnold S Bayer, Yan Q Xiong
1Department of Medicine, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, USA.
Abstract:
Endovascular infections, including endocarditis, are life-threatening infectious syndromes. Staphylococcus aureus is the most common world-wide cause of such syndromes with unacceptably high morbidity and mortality even with appropriate antimicrobial agent treatments. The increase in infections due to methicillin-resistant S. aureus (MRSA), the high rates of vancomycin clinical treatment failures and growing problems of linezolid and daptomycin resistance have all further complicated the management of patients with such infections, and led to high healthcare costs. In addition, it should be emphasized that most recent studies with antibiotic treatment outcomes have been based in clinical settings, and thus might well be influenced by host factors varying from patient-to-patient. Therefore, a relevant animal model of endovascular infection in which host factors are similar from animal-to-animal is more crucial to investigate microbial pathogenesis, as well as the efficacy of novel antimicrobial agents. Endocarditis in rat is a well-established experimental animal model that closely approximates human native valve endocarditis. This model has been used to examine the role of particular staphylococcal virulence factors and the efficacy of antibiotic treatment regimens for staphylococcal endocarditis. In this report, we describe the experimental endocarditis model due to MRSA that could be used to investigate bacterial pathogenesis and response to antibiotic treatment.
Insights
This study details a rat model for investigating Staphylococcus aureus endocarditis, crucial for understanding disease and testing new treatments against resistant strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Animal Models
Background:
- Endovascular infections, particularly Staphylococcus aureus endocarditis, present significant morbidity and mortality.
- Increasing antibiotic resistance (MRSA, vancomycin, linezolid, daptomycin) complicates treatment and increases healthcare costs.
- Clinical studies are limited by patient-specific host factors, necessitating reliable animal models.
Purpose of the Study:
- To describe an experimental endocarditis model in rats using methicillin-resistant Staphylococcus aureus (MRSA).
- To establish a reproducible model for investigating bacterial pathogenesis and antibiotic efficacy in endovascular infections.
- To provide a standardized platform for evaluating novel antimicrobial agents against S. aureus.
Main Methods:
- Development and characterization of an experimental endocarditis model in rats.
- Infection induced by Staphylococcus aureus, specifically methicillin-resistant strains (MRSA).
- Utilizing the rat model to mimic human native valve endocarditis for research purposes.
Main Results:
- The rat endocarditis model effectively replicates key aspects of human native valve endocarditis.
- This model allows for controlled investigation of S. aureus virulence factors and antibiotic responses.
- The model is suitable for assessing the efficacy of various antibiotic treatment regimens.
Conclusions:
- The described experimental endocarditis model in rats is a valuable tool for studying MRSA pathogenesis.
- This model facilitates the evaluation of novel antimicrobial therapies for endovascular infections.
- A standardized animal model is essential for advancing the understanding and treatment of staphylococcal endocarditis.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
01:25Mechanism of Antibiotic Resistance in MRSA